Neuroinflammation commonly accompanies neurodegeneration, but the specific roles of resident and infiltrating immune cells during degeneration remains controversial. Much of the difficulty in assessing myeloid cell-specific functions during disease progression arises from the inability to clearly distinguish between activated microglia and bone marrow-derived monocytes and macrophages in various stages of differentiation and activation within the central nervous system. Using an inducible model of photoreceptor cell death, we investigated the prevalence of infiltrating monocytes and macrophage subpopulations after the initiation of degeneration in the mouse retina. In vivo retinal imaging revealed infiltration of CCR2 + leukocytes across retinal vessels and into the parenchyma within 48 hours of photoreceptor degeneration. Immunohistochemistry and flow cytometry confirmed and characterized these leukocytes as CD11b + CD45 + cells. Single-cell mRNA sequencing of the entire CD11b + CD45 + population revealed the presence of resting microglia, activated microglia, monocytes, and macrophages as well as 12 distinct subpopulations within these four major cell classes. Our results demonstrate a previously immeasurable degree of molecular heterogeneity in the innate immune response to cell-autonomous degeneration within the central nervous system and highlight the necessity of unbiased high-throughput and high-dimensional molecular techniques like scRNAseq to understand the complex and changing landscape of immune responders during disease progression.
Results

Invasion of peripheral immune cells into the rapidly degenerating retina. The Arr1
−/− mouse is a convenient, light-inducible model of widespread, cell-autonomous photoreceptor neurodegeneration 14, 17 . Previous studies have shown that within 24 hours of light onset, microglia change morphology and migrate into the photoreceptor layer, and between 36 and 72 hours after light onset there is a dramatic increase in the number of Iba1
+ cells present in the retina 18 . We first aimed to investigate the source of this increase in cell number using immunohistochemistry on Arr1 −/− retinas exposed to 48 hours of light. Sections of retina immunohistochemically stained for CD11b, a pan-myeloid cell marker, showed the presence of enlarged macrophage-like cells in and around the photoreceptors and subretinal space. Additionally, there were small round CD11b
+ monocyte-like cells often visible at the vitreoretinal surface and retinal layers of light exposed mice that were never observed when the animals were maintained in darkness (Fig. 1a) .
Monocyte extravasation into the retina has been implicated in other mouse models of retinal and RPE damage known to disrupt the blood-retina barrier (for example, see 6 ). However, to our knowledge, leukocyte infiltration has not been previously known to occur in any models of cell-autonomous retinal neurodegeneration. To confirm the presence of infiltrating cells in vivo, we crossed Arr1 −/− mice with Ccr2 RFP/RFP knock-in mice that express RFP downstream of the Ccr2 promoter. Using scanning laser ophthalmoscopy, we could detect very little RFP + signal within the retinas of dark-reared Arr1 −/− Ccr2 +/RFP mice. However, when the same mouse was imaged after 48 hours of light exposure, many RFP + cells were evident within the retinal parenchyma (Fig. 1b, red) , consistent with monocyte infiltration. These cells were distinct from microglial cells, which showed a different morphology and pattern of distribution at this same time point in vivo (Arr1 −/− Cx3CR1 +/GFP ; Fig. 1b , green). These results suggest that there are multiple distinct populations of immune cells that rapidly respond at the onset of photoreceptor degeneration.
Single cell profiling reveals four classes of CD11b
+ CD45 + cells. To more precisely identify resident and peripheral immune cell classes in the retina we used single-cell RNA sequencing. Retinas of healthy dark-reared control and degenerating (light-exposed) Arr1 −/− littermates were dissociated, and all live cells expressing both CD11b and CD45, which include both microglia and monocytes, were collected using FACS for single-cell RNA sequencing (Fig. 2, black polygon) . Posthoc analysis of the collected cells showed a dramatic increase in the number of CD11b + CD45 high cells (Fig. 2 , green box), consistent with the invasion of peripheral cells seen by in vivo imaging. Interestingly, there was also an increase in the number of CD11b − CD45 high cells during degeneration (Fig. 2) ; these cells were not captured for scRNAseq and will be the subject of future study.
Single-cell mRNA libraries of CD11b + CD45 + cells were generated and sequenced with stringent pre-processing and quality control cell filtering. The transcriptomes of all cells were compared using principal components analysis, and data were displayed in two dimensions using a t-distributed stochastic neighbor embedding (tSNE) plot where the relative position of each point reflects the genetic similarity of the cell to others in the population. The majority of immune cells in the dark-reared control sample (Fig. 3a, red) formed a well-defined cloud that did not overlap with cells from the degenerating retina. Instead three new qualitatively distinct clouds emerged in the degenerating sample (Fig. 3a, blue) . This dissimilarity of control and degenerating samples from Arr1 −/− littermates indicates that the gene expression profiles themselves were not grossly affected by tissue processing, and suggests that these four clouds represent the presence of four distinct classes of CD11b + CD45 + cells (Fig. 3b) . To test whether the clouds indeed correspond to distinct cell classes, we queried the expression of numerous known or proposed microglia, monocytes, and macrophages markers across all cells (at least 15 markers per group). The expression of these markers was first examined graphically, by displaying the relative expression of each gene on a tSNE plot. Cloud #1 (Fig. 3b, orange) , which was present only in control retina, expressed the highest levels of resting microglia markers, such as P2ry12 and Tmem119 (Fig. 3d) ; Cloud #2 (Fig. 3b, green) contained markers of microglial activation, such as Lpl and Cst7 (Fig. 3e ) 19, 20 . Cloud #3 (Fig. 3b , blue) contained abundant monocyte markers such as Ly6c2 and Ccr2 (Fig. 3f) , and in Cloud #4 (Fig. 3b, purple) markers of monocyte-derived macrophages like H2-Aa (an MHCII gene) and Cd74 were most highly expressed (Fig. 3g ) 21 . For further graphical examples of marker gene expression, see Supplemental Fig. 1 . Queries for markers of other immune and retinal cell types, including dendritic cells, neutrophils, and T and B cells, did not identify any other major cell types in the dataset, as expected since only CD11b + cells were selected for analysis. To independently identify differences in gene expression between these clouds, we used Seurat to generate lists of abundant transcripts differentially expressed in each Cloud relative to all other cells. These lists were rife with many known marker genes for these cell types (Supplemental Table 1 ), including several of the markers queried in Fig. 3 and Supplemental Fig. 1 . Thus, both candidate gene expression queries and unbiased transcriptional
In silico identification of cell subtypes with different activation and proliferation states. To objectively identify transcriptionally distinct groups of cells, we used an unsupervised in silico graph-based clustering algorithm 22 . This algorithm identified 12 distinct clusters, corresponding to 12 putative populations (Fig. 3c) . One cluster fell within the cloud deemed resting microglia (Fig. 3c , Cluster #1); four clusters fell within the cloud of activated microglia (Clusters #2-5); three clusters fell within the cloud of monocytes (Clusters #6-8); two fell within the cloud of monocyte-derived macrophages (Clusters #9-10); and two very small clusters could not be confidently identified as any immune or retinal cell type (Clusters #11-12).
To identify potential functional differences between these putative subpopulations, we used Seurat to determine the genes most differentially expressed between clusters (Supplemental Table 2 for list and p-values). Genes associated with specific functional states like inflammation, proliferation, and phagocytosis were enriched in particular subsets of clusters (Fig. 4) . For example, expression of the inflammatory cytokines, such as Il-1β, was highest in monocytes and macrophages (Fig. 4a , Clusters #6-10). Cluster #6 contained cells from both control and degenerating samples that expressed markers for peripheral immune cells like Plac8, suggesting that these were circulating cells captured in the vasculature at the time of dissection. The majority of cells of only two of the clusters (Clusters #4, #10) expressed genes associated with cell division, such as Cdk1 and Pclaf, suggesting that these subpopulations were actively proliferating (Fig. 4b) . Finally, another small but distinct cluster contained + cells that were round appeared in the vitreous and nerve fiber layer (NFL) near large caliber vessels while those that were ameboid were present in the subretinal space (SR) and photoreceptor layer (outer nuclear layer, ONL). Scale bars indicate 25 µm, INL = inner nuclear layer. (b) In vivo retinal imaging using scanning laser ophthalmoscopy. Cells expressing RFP driven by the CCR2 promoter (putative monocytes) appeared abruptly within 48 hours of light exposure (compare 0 to 48 hours exposure taken from the same mouse), while the number of GFP expressing resident microglia of changed little. Insets show corresponding reflectance images.
www.nature.com/scientificreports www.nature.com/scientificreports/ some photoreceptor-specific transcripts involved in rod phototransduction, such as Guca1a and Cngb1 (Fig. 4d , subset of Cluster #5). We interpret this to mean that these activated microglia had phagocytosed rods containing non-degraded mRNA immediately before tissue processing.
Microglia (Clusters #1-5) expressed many complement-related genes (Supplemental Table 2 ), but the relative expression patterns between clusters were not uniformly helpful in identifying potential functional subpopulations. For example, C1q component genes like C1qa (Fig. 4c) and some integrin subunits (data not shown) were expressed at similar levels in both control and degenerating samples, suggesting that microglia are capable of initiating the classical complement pathway in both resting and activated states. In contrast, Complement Factor H (Cfh), which inhibits the alternative complement pathway and has been linked to age-related macular degeneration 23, 24 , was decreased in the degenerating sample and did not differ much between activated microglia subpopulations (Fig. 4c) .
Since distinct subpopulations of activated microglia have been previously identified in Alzheimer's disease and ALS 19 , we examined if those previously defined activated stages were sufficient to describe the subpopulations identified here (Fig. 4e) . Keren-Shaul and colleagues suggested that microglia activation occurred in two stages, so we examined the expression of markers for both stages across all microglia clusters. Although many of the same resting microglia markers were expressed in our control sample (Cluster #1; Fig. 4e , top row), the relative expression profiles of activated microglia clusters did not consistently align with the activation progression observed in Alzheimer's disease and ALS. For example, Lyz2 and Apoe, two genes that were previously associated with stage one of activation in Alzheimer's Disease, were only enriched in one of the four activated microglia clusters (Cluster #2), yet another prominent Stage 1 marker, Cstb, was not similarly enriched in this cluster (Fig. 4e , middle row). Clusters #3-5 expressed some genes associated with the second stage of activation, such as Spp1 and Cd63, but there was a marked absence of others, such as Cst7 (Fig. 4e, bottom row) . Additionally, several of these genes and others have been identified as being differentially expressed in activated brain microglia after lysolecithin demyelination 20 . However, the relative expression and subpopulations again do not align precisely (see Supplemental Fig. 1 for further examples of lysolecithin demyelination-related genes expression during Arr1 −/− degeneration). These findings suggest that although some features of microglia activation may be conserved, the specific molecular phenotypes and subpopulations may depend on the tissue, type, and extent of neuronal degeneration.
Re-examining molecular heterogeneity of the immune response in the context of degeneration.
Translating the insights garnered from the single-cell data into the framework of retinal structure and more traditional methodologies is essential for subsequently testing and manipulating immune cell function during degeneration. As a first step, we focused on MHCII, a common marker of monocyte-derived macrophages 25 that indeed showed prominent expression in those corresponding clusters (Fig. 5a , H2-Aa, Clusters #9-10). FACS www.nature.com/scientificreports www.nature.com/scientificreports/ detection of MHCII antibody staining revealed a dramatic increase in MHCII protein levels in CD45 + CD11b + cells from the degenerating retina (Fig. 5c , blue box, compare control to degenerating; see Fig. 5b for gating strategy). The same MHCII antibody when applied to immunohistochemistry stained only a fraction of CD11b + cells, as best illustrated by looking at a population of cells across a large retinal area in flat mounts (Fig. 5e) . In retinal sections, MHCII + cells were not localized in any particular layer but instead were distributed throughout the retina, from the vitreal surface to the outer plexiform layer (Fig. 5d ). This suggests either that the monocyte-derived macrophages did not rapidly accumulate in the photoreceptor layers or that the differentiation from monocyte to macrophage happened well before the cells arrived at their final destination. Notably, there were no clear morphological distinctions between MHCII + and MHCII − populations, emphasizing the inadequacy of using morphology for discriminating between activated microglia and monocyte-derived macrophages in this instance.
Through scRNAseq we also identified two subpopulations of proliferating cells in denerating retina (Fig. 4b , Clusters #4, 10). Utilizing IHC, we confirmed the presence of mitotically active Cd11b
+ cells using Ki67 staining in degenerating tissue. Again, Ki67
+ cells were not localized to a particular retinal region and instead seemed www.nature.com/scientificreports www.nature.com/scientificreports/ equally scarce in both inner and outer retinal layers (Fig. 5e , example shown in outer retina). In contrast, Ki67 + nuclei were never observed in dark-reared control retinas, consistent with the scRNAseq findings.
In some cases, our scRNAseq data revealed cellular heterogeneity in the expression of genes commonly considered to be cell type-specific markers. For example, Ccr2, a common monocyte marker (e.g. 25 ), was detectable in both monocyte and macrophage populations (Clouds #3 and #4; Fig. 5a ), though indeed only statistically differentially expressed in monocyte Cloud #3 (1.5-fold higher expression; p = 1.35E-26; Supplemental Table 1) . Notably,within Cloud #3 it was only differentially expressed in the inflammatory monocytes of Cluster #8 (1.8-fold higher expression, p = 3.30E-29 Supplemental Table 2 ), and not the other monocyte clusters. Antibody labeling and detection using FACS showed a similar modest increase in total CCR2 staining between control and degenerating retinas (Fig. 5c, red box) . However, neither FACS nor scRNAseq results were as dramatic as the evident infiltration revealed by in vivo imaging of Ccr2 +/RFP retinas (Fig. 1b) , possibly reflecting a difference in the lifetime of the RFP protein as compared to CCR2.
Discussion
The present study uses scRNAseq to reveal distinct subpopulations of immune responders within the retina. In combination with in vivo imaging, flow cytometry, and immunohistochemistry, our results show that microglial activation, monocyte infiltration, and monocyte differentiation into macrophages can occur concurrently and rapidly, within 48 hours after the onset of photoreceptor degeneration. Here we describe the distinguishing molecular features of these subpopulations and discuss the consequences of these findings for retinal degeneration and neuroinflammation more generally.
Distinguishing hallmarks of immune subpopulations in the degenerating retina. Rigorous analysis of the scRNAseq dataset generated here revealed the presence of distinct populations and subpopulations of both invading and resident myeloid cells, consistent with in vivo imaging (Fig. 1b) , FACS analysis (Figs 2 and www.nature.com/scientificreports www.nature.com/scientificreports/ 5b,c), and immunohistochemistry (Figs 1a and 5d,e) . Figure 6a outlines the distribution of immune subpopulations by location (retina vs. blood), condition (control vs degenerating), cloud group, and cluster number. In control retina, almost all of the immune cells were resident microglia; the majority (72.4%) of which were resting, compared to 22.8% activated. The remaining immune cells in control retina were circulating monocytes trapped in the blood stream (4.4%). Remarkably, in degenerating tissue the majority of immune cells (64%) were peripheral in origin, and at the time point investigated here were comprised roughly equally of infiltrating monocytes (35.1%) and monocyte-derived macrophages (28.8%). Only 30.7% of the immune cells in the degenerating retina were activated, resident microglia.
Statistical comparison of transcriptional profiles revealed distinct subpopulations with clear and often dramatic differences in gene expression between them. Figure 6b lists the top 10 significantly differentially expressed genes for each cluster and cloud, sorted by the adjusted p-value (see Supplemental Tables 1 and 2 for an extended list and all p-values) and categorized into functional groups based on gene expression in the cluster subpopulations. For example, proliferating microglia and monocytes (Clusters #4 and #10, respectively) both express significantly higher levels of Pclaf (2810417H13Rik) compared to all other cells, indicating that these cells were undergoing DNA replication and establishing their status in the proliferating functional group. Nonetheless, the www.nature.com/scientificreports www.nature.com/scientificreports/ molecular profile of numerous other genes within these clusters allowed us to simultaneously classify them into two distinct subpopulations of activated microglia and macrophages. Similarly, the molecular profile of Clusters #1-5 clearly identify these as Resting (#1) and Activated (#2-5) microglia; however the more subtle differences between Clusters #2, #3, and #5 raise the question as to whether the activated microglia clusters represent stages of one continuous activation pathway or functionally distinct pathways. Finally, the key cloud genes (Fig. 6b, Understanding molecular heterogeneity is critical for potential functional analysis. In addition to revealing subpopulations of each cell class, the scRNAseq analysis allows inference about the potential function(s) of individual subpopulations to ascertain the role they play during neurodegeneration. For example, Macrophages (Cloud #4, Clusters #9, #10) showed significantly higher levels of H2-Aa expression, an MHCII gene associated with antigen processing and presentation compared to all other groups (Fig. 5a , Supplemental Tables 1,  2 ). Retinal MHCII + cells, especially in the subretinal space, have been described in models of RPE death 6 , and after light injury in Cx3cr1 −/− 7 , RPE65 Leu/Leu , and wild-type mice 8 . Our immunohistochemistry revealed that MHCII + cells were localized throughout all of the retinal layers and were not morphologically distinct from other CD11b + cells. The differences in the localization and appearance of MHCII + cells in these various models of degeneration may reflect differences in the site of infiltration, either across Bruch's membrane and RPE, or, as in the present study, across retinal vessels.
Another potential functional inference that can be drawn from the data is the role of CCL2-CCR2 signaling, which is widely known to recruit systemic immune cells during retinal degeneration. Here we found that Ccl2 was detectable in all of the immune subgroups (Fig. 5a) , and notably not differentially increased in activated microglia, suggesting they are not the source of CCL2 to recruit infiltrating monocytes at this time point. Conversely, Monocytes (Cloud #3) and Macrophages (Cloud #4) showed expression of Ccr2, the CCL2 receptor (Fig. 5a) , with considerable variability in expression between Clusters #6-10. This variability may reflect the rapid degradation of CCR2 and downregulation of Ccr2 expression after extravasation into the retinal parenchyma. Indeed, in the Tables 1 and 2 for an extended list, see Methods for description of how lists were created). Expression of genes in bold are also shown graphically throughout www.nature.com/scientificreports www.nature.com/scientificreports/ Cx3cr1 −/− model of age-related macular degeneration, it has been shown that monocytes downregulate Ccr2 rapidly when differentiating into macrophages 7 . Surprisingly, we found a distinct lack of anti-inflammatory markers, such as Il10 (Fig. 4a) , in all cells, even in the resting microglia population. Because monocytes and macrophages are capable of adopting both pro-and anti-inflammatory phenotypes 25 , it is possible that anti-inflammatory cells may play a role in the response to photoreceptor degeneration at later time points, or as the rate of degeneration slows and the tissue enters a homeostatic "recovery" phase. It is also possible that anti-inflammatory signaling is more prevalent in slower models of retina degeneration.
Implications for photoreceptor degeneration and other retinal degenerative diseases. Many mouse models have been described with genetic and/or phenotypic similarities to human retinal degenerative diseases with varying ages of onset and speed of degeneration [26] [27] [28] . While all models involve activation of resident microglia, the potential involvement of the peripheral immune system remains unclear. In some instances, such as in cases of RPE and/or light damage, monocytes and macrophages have been detected in the degenerating retina 5, 8 , though it has not been resolved whether they enter through the retinal or choroidal vasculature. Arrestin-1 is distinctly a photoreceptor-specific protein that is not expressed in leukocytes 29, 30 or other cells of the retina 31 . Arr1 binds photoexcited rhodopsin 32 , quenching its ability to activate G-protein in the phototransduction cascade of vertebrate rods. Mice lacking Arr1 have normal retinal morphology when reared in complete darkness, yet when they are exposed to light, unrestrained rhodopsin signaling causes photoreceptors to rapidly degenerate over the course of a few days 12, 15, 17 even in relatively dim light 18 . Thus, the Arr1 −/− mouse serves as a model for time-locked, light-induced photoreceptor degeneration, allowing the acute response of both resident and infiltrating immune cells to be followed consistently in time. The ability to chart the immune response to a time-locked degeneration onset is especially critical for studying the differentiation of monocytes into macrophages within the CNS, and how these interactions may change over time. ScRNAseq in time-locked models will be important to determine how microglia and infiltrating immune cells re-establish surveillance in degenerated retina and their immune responses to therapies and subsequent insults related to aging.
In summary, scRNAseq revealed a previously immeasurable degree of heterogeneity in the myeloid response to cell-autologous degeneration of neurons within the central nervous system, including changes in the local resident populations and an invasion of immune cells from the periphery (Fig. 6) . The complex differences between populations observed here highlight the necessity of utilizing unbiased high-throughput and high-dimensional molecular techniques like scRNAseq in combination with techniques like immunohistochemistry, in vivo imaging or ultimately spatial transcriptomics 33, 34 .
Methods
Animals. Mice , respectively). All mice used in this study were between 2-4 months old. Although there are reports of sex differences in microglia function and reactivity 37 , no differences were observed in immunohistochemistry or in vivo microglial imaging experiments (data not shown); thus, both male and female animals were used and the results combined. To avoid sex-specific differences in gene expression, only retinas from female mice were used for scRNAseq. Six littermates (3 dark-reared controls and 3 degenerating, 48 hours light-exposed mice) were used for single-cell sequencing in order to capture a sufficient number of high quality cells, ideally approximately 200 cells of any significant immune cell type 38 . Female littermates were randomly divided between control and degenerating groups.
Immunohistochemistry. Immunohistochemistry was performed as previously described 39 . Briefly, mice were sacrificed by carbon dioxide euthanasia and eyes enucleated and submerged in 4% paraformaldehyde at room temperature. After 5 minutes of fixation, the cornea and lens were removed, and the eyecups were fixed for an additional 20-25 minutes. For retinal sections, fixed eyecups were embedded in agarose and sectioned on a vibratome (Leica) at a thickness of 150 µm. Sections were blocked at room temperature in normal serum, incubated in primary antibody solution at 4 °C overnight, washed in PBS 3 times for 15 minutes each, and incubated in secondary antibody solution at room temperature for 1.5-2 hours before an additional 3 PBS washes and mounting with ProLong Diamond Antifade (Invitrogen). For retinal flatmounts, retinas were removed from fixed eyecups, followed by incubation in 1% Triton X-100 in PBS overnight at 4 °C, and then blocked with normal serum for 2 hours at 37 °C. Retinas were incubated in primary antibody solution overnight at 4 °C, washed 3 times in PBT for 15-30 minutes at room temperature, and incubated in secondary antibody solution for 1.5-2 hours at 37 °C before 3 PBT washes and mounting with ProLong Diamong Antifade with DAPI (Invitrogen). Tissue was stained for Ki67 using an antibody raised in rabbit (1:300; Abcam), followed by Alexa Fluor-conjugated secondary antibody (1:300; Invitrogen); rat antibodies against CD11b and MHCII (1:300 and 1:200 respectively; BioLegend) were preconjugated to Alexa Fluors and added to the seconday antibody solution; DAPI (Invitrogen) was also added to the secondary antibody solution (2 drops/mL). All sections and flatmounts were imaged using a Nikon A1 confocal microscope.
In vivo imaging with scanning laser ophthalmoscopy. A custom-built scanning laser ophthalmoscopy (SLO) system was used to image GFP + and RFP + cells within the retina, simultaneously collecting the reflectance and fluorescence images 40 . For imaging, mice were anesthetized with 2-2.5% isoflurane and positioned on a heating pad (37 °C) with a micropositioner (Bioptigen, Morrisville, NC) that allowed rotational and translational (2019) 9:4858 | https://doi.org/10.1038/s41598-019-41141-0 www.nature.com/scientificreports www.nature.com/scientificreports/ adjustment for positioning the mouse with respect to the contact lens. The pupils were dilated and cyclopleged with tropicamide and phenylephrine, and the corneal surface wetted with Gel Tears hypromellose gel (GenTeal Tears Severe, Alcon). Gel Tears helped maintain a homogeneous refractive surface between the cornea and the custom 0 diopter contact lens (Unicon Corporation, Osaka, Japan). GFP and RFP excitation was achieved with 488 nm and 561 nm lasers, respectively. Images were collected over 51° of visual angle at 43 µm per degree. In Fiji 41 , images were registered 42 , averaged, background subtracted, and pseudo-colored for presentation.
Fluorescence activated cell sorting (FACS).
FACS was performed using a protocol modified from an established method 8, 17 . After dissection, each retina was incubated in 1 mL of digestion buffer containing: Hank's Balanced Salt Solution (10-547 F, Lonza), 5% Fetal Bovine Serum (FBS; 35010CV, Corning), 10 mM HEPES, 0.7 mg/mL calcium chloride, 1.5 mg/mL Collagenase A (10103586001, Roche), and 0.1 mg/mL DNase I (10104159001, Roche) at 37 °C for 15 minutes. Following incubation, each retina was gently dissociated and the resulting single-cell suspension was washed, filtered through a 70 µm cell strainer, centrifuged at 350xg for 5 minutes, and resuspended in PBS. Cells were stained for viability (Zombie Viability NIR, Biolegend), and blocked with Fc light chain antibodies (eBiosciences), supplemented with normal rat serum and normal mouse serum. Cells were then incubated with anti-mouse CD11b conjugated to BV605, anti-mouse CD45 conjugated to PE, anti-mouse CCR2 conjugated to PE/Cy7, and anti-mouse AI/IE (MHCII) conjugated to BV711 (all Biolegend). Cell suspensions were washed in PBS containing 0.5% Bovine Serum Albumin (BSA), centrifuged at 350 × g for 5 minutes, and resuspended in 0.5% BSA in PBS with 1:50 EDTA. All retinas were processed separately, until being combined by group (6 retinas from 3 dark-reared, control mice and 6 retinas from 3 light-exposed, degenerating mice) immediately before sorting. Cells were sorted into 40 µL of ice cold DMEM supplemented with 10% FBS using the MoFlo Astrios cell sorter (Beckman) at the UC Davis Flow Cytometry Core, gating for alive CD11b + CD45 + cells. Further analysis was performed using FlowJo.
Single-cell RNA library preparation and sequencing. Sequencing libraries were prepared from the sorted CD11b + CD45 + cells from each group (control and degenerating samples) using the 10X Genomics system (Chromium) at the UC Davis DNA Technologies and Expression Core according to manufacturer recommendations. The two resulting cDNA libraries were sequenced on a NextSeq (Illumina) system running 150 cycles of paired-end reads at the UC Davis DNA Technologies and Expression Core according to manufacturer recommendations. The transcript read lengths were 98 bp, and the sample index, cell barcode, and UMI read lengths were 8 bp, 14 bp, and 10 bp respectively. Cells were sequenced at a mean depth of 474,191 reads per cell in the control library and 225,889 reads per cell in the degenerating library. The scRNAseq dataset generated and analyzed here is available in the NCBI Gene Expression Omnibus (GEO) repository, accession number GSE121081.
scRNAseq Analysis. Initial sequence processing, including barcode processing, transcript alignment, and generation of gene-barcode matrices were performed using Cell Ranger (Chromium) at the UC Davis Bioinformatics Core. Further processing and analysis was performed in R, primarily with the Seurat package unless otherwise specified [43] [44] [45] . Cells were examined for quality control, removing those with unique gene counts over 3,000 (to remove potential doublets from the dataset) and under 500 (to remove spurious contamination). Data were then normalized for unique molecular identifier (UMI) counts per cell and mitochondrial genes following the standard Seurat workflow. After principal components analysis, the transcript expression from the top ten principal components was used to perform t-distributed stochastic neighbor embedding (tSNE) dimensional reduction. Clusters were identified using a graph-based local moving algorithm with a resolution of 1.5 22 . This resolution was selected after trying a wide range of resolution values (0.6-1.6) and decided upon in consultation with the UC Davis Bioinformatics Core, based upon the generation of a similar number of clusters across several resolutions and reasonable numbers of differentially expressed genes between clusters. Expression of marker genes were identified using the FindMarkers function in Seurat. This function identifies genes differentially expressed in a given group (either a cluster or cloud) compared to all other cells in the dataset using a non-parametric Wilcoxon rank sum test followed by Bonferroni correction. For each cluster or cloud, p-value adjustments were based on the total number of genes expressed in at least 25% of the cells in the cluster or cloud being tested.
